It is a 10 ml saline cell suspension developed and formulated by Genkord, consisting of an average of 200 million cells obtained from the patient’s bone marrow.

Product Content

CD34 + Hematopoietic Stem Cell 200 million

+90 533 665 89 71
Category:

Description

Mechanism of Action

OXYSOME™ are stem cell-derived treatment support products developed by Genkord especially to support angiogenesis and revascularization. Hematopoietic Stem Cells are found especially in bone marrow and cord blood. Especially neovascularization effects, since there are blood cells and cells responsible for vascular formation in the body; They show through exosomes containing VEGF, signaling molecules and miRNAs.

The neovascularization effects of OXYSOME™ are recommended as a supportive treatment for all ischemic-based post-traumatic and systemic diseases, especially in solving problems related to malnutrition of end organs such as the heart, brain, eyes and feet.

 

Application Method

  • IV
  • IT 
  • PROVINCE
  • IA 
  • ID

 

The neovascularization effects of OXYSOME™ are recommended as a supportive treatment for all ischemic-based post-traumatic and systemic diseases, especially in solving problems related to malnutrition of end organs such as the heart, brain, eyes and feet.

Reviews

There are no reviews yet.

Be the first to review “OXYSOME™”

Your email address will not be published. Required fields are marked *